Aeon Metals Limited News - AMLN

Professional-Grade Tools, for Individual Investors.

UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval

(Adds detail, analyst and CSO comments.) By Gustav Sandstrom Of DOW JONES NEWSWIRES Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO...

Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO

Novo Nordisk A/S (NOVO-B.KO) expects its closely-watched diabetes treatment Victoza to reach European customers in the nearest future, Chief...

Doctors Say New Diabetes Drugs Hold Great Promise

By nearly every measure, it has been a successful weekend for a new wave of proposed drugs that doctors are hailing as the most promising...

CORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's Byetta

Novo Nordisk's (NVO) proposed once daily diabetes drug is substantially better at controlling blood glucose in patients with Type 2 diabetes when...

Novo Nordisk Diabetes Drug Liraglutide Successful In Study

Novo Nordisk A/S's (NOVO-B.KO)once-daily diabetes treatment liraglutide is substantially better at controlling blood glucose levels in type 2...

UPDATE: Weekly Diabetes Drug Byetta Outdoes Competitors

A once-a-week version of the diabetes drug Byetta, by Amylin Pharmaceuticals Inc. (AMLN), was better at controlling blood glucose levels and...

Study Shows Weekly Byetta Diabetes Drug Outdoes Competitors

A once-a-week version of the diabetes drug Byetta by Amylin Pharmaceuticals Inc. (AMLN) was better at controlling blood glucose levels and...

UPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead Dir

(Adds background about Cook and Wilson.) DOW JONES NEWSWIRES Amylin Pharmaceuticals Inc. (AMLN) said Chairman Joseph C. Cook Jr. and lead director...

Amylin: 2 Dissidents To Replace Chairman, Lead Director

Amylin Pharmaceuticals Inc. (AMLN) said Chairman Joseph C. Cook Jr. and lead director James N. Wilson were not re-elected to the board as two...

UPDATE: Amylin: Dissidents Likely Got Up To Two Board Seats

(Adds information from company beginning in the first paragraph and updated stock price.) DOW JONES NEWSWIRES Amylin Pharmaceuticals Inc. (AMLN...

Eastbourne Claims Success In Electing Directors To Amylin Board

Eastbourne Capital Management, which along with Carl Icahn has been in a contentious dispute with management at Amylin Pharmaceuticals Inc...

Hedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin Slate

A major shareholder of Amylin Pharmaceuticals Inc. (AMLN) is backing a slate of dissident directors nominated by Carl Icahn and another hedge-fund...

More Proxy Advisers Back Dissidents' Amylin Board Nominees

Two more proxy advisers have come out in support of non-company nominees to Amylin Pharmaceuticals Inc. (AMLN) board as part of a fight between...

UPDATE: Risk Metrics Backs Three Dissident Amylin Directors

Proxy advisory Risk Metrics, formerly known as ISS, has recommended that Amylin Pharmaceuticals Inc. (AMLN) shareholders elect three dissident...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aeon Metals Limited (AMLN)

Professional-Grade Tools, for Individual Investors.

AMLN News

UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval

Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO

Doctors Say New Diabetes Drugs Hold Great Promise

CORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's Byetta

Novo Nordisk Diabetes Drug Liraglutide Successful In Study

UPDATE: Weekly Diabetes Drug Byetta Outdoes Competitors

Study Shows Weekly Byetta Diabetes Drug Outdoes Competitors

UPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead Dir

Amylin: 2 Dissidents To Replace Chairman, Lead Director

UPDATE: Amylin: Dissidents Likely Got Up To Two Board Seats

Eastbourne Claims Success In Electing Directors To Amylin Board

Hedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin Slate

More Proxy Advisers Back Dissidents' Amylin Board Nominees

UPDATE: Risk Metrics Backs Three Dissident Amylin Directors

AMLN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Aeon Metals Limited (AMLN) News

Aeon Metals Limited (AMLN)

Professional-Grade Tools, for Individual Investors.

AMLN News

UPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU Approval

Novo Nordisk's Victoza To Reach Market In A Few Weeks - CSO

Doctors Say New Diabetes Drugs Hold Great Promise

CORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's Byetta

Novo Nordisk Diabetes Drug Liraglutide Successful In Study

UPDATE: Weekly Diabetes Drug Byetta Outdoes Competitors

Study Shows Weekly Byetta Diabetes Drug Outdoes Competitors

UPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead Dir

Amylin: 2 Dissidents To Replace Chairman, Lead Director

UPDATE: Amylin: Dissidents Likely Got Up To Two Board Seats

Eastbourne Claims Success In Electing Directors To Amylin Board

Hedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin Slate

More Proxy Advisers Back Dissidents' Amylin Board Nominees

UPDATE: Risk Metrics Backs Three Dissident Amylin Directors

AMLN Discussion

Your Recent History